These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 24138426)
41. Therapeutic efficacy of renin-angiotensin blockade in patients receiving dialysis. Suzuki H Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):397-405. PubMed ID: 19491138 [TBL] [Abstract][Full Text] [Related]
42. Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors. Liao S; Miralles M; Kelley BJ; Curci JA; Borhani M; Thompson RW J Vasc Surg; 2001 May; 33(5):1057-64. PubMed ID: 11331849 [TBL] [Abstract][Full Text] [Related]
43. Pathophysiological role of the renin-angiotensin system on erectile dysfunction. Fraga-Silva RA; Montecucco F; Mach F; Santos RA; Stergiopulos N Eur J Clin Invest; 2013 Sep; 43(9):978-85. PubMed ID: 23909886 [TBL] [Abstract][Full Text] [Related]
44. Downregulation of remodelling enzymatic activity induced by an angiotensin-converting enzyme inhibitor (perindopril) reduces the degeneration of experimental abdominal aortic aneurysms in a rat model. Alsac JM; Journe C; Louedec L; Dai J; Julia P; Fabiani JN; Michel JB Eur J Vasc Endovasc Surg; 2011 Apr; 41(4):474-80. PubMed ID: 21256058 [TBL] [Abstract][Full Text] [Related]
45. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension]. Abassi Z; Armaly Z; Nakhoul F; Hoffman A Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632 [TBL] [Abstract][Full Text] [Related]
46. Rationale for combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor treatment and end-organ protection in patients with chronic kidney disease. Toto R; Palmer BF Am J Nephrol; 2008; 28(3):372-80. PubMed ID: 18073461 [TBL] [Abstract][Full Text] [Related]
47. The role of the central renin-angiotensin system in Parkinson's disease. Mertens B; Vanderheyden P; Michotte Y; Sarre S J Renin Angiotensin Aldosterone Syst; 2010 Mar; 11(1):49-56. PubMed ID: 19861346 [TBL] [Abstract][Full Text] [Related]
48. Preventing end-stage renal disease in diabetic patients - dual blockade of the renin-angiotensin system (Part II). Jacobsen PK J Renin Angiotensin Aldosterone Syst; 2005 Sep; 6(2):55-68. PubMed ID: 16470484 [TBL] [Abstract][Full Text] [Related]
49. Significance of matrix metalloproteinase-9 inhibition by imidapril for prevention of abdominal aortic aneurysms in angiotensin II type 1 receptor-knockout mice. Takai S; Jin D; Yamamoto D; Li ZL; Otsuki Y; Miyazaki M J Pharmacol Sci; 2013; 123(2):185-94. PubMed ID: 24096831 [TBL] [Abstract][Full Text] [Related]
50. Comparative study of vasodilators in an animal model of chronic volume overload caused by severe aortic regurgitation. Plante E; Lachance D; Beaudoin J; Champetier S; Roussel E; Arsenault M; Couet J Circ Heart Fail; 2009 Jan; 2(1):25-32. PubMed ID: 19808312 [TBL] [Abstract][Full Text] [Related]
51. Acute kidney injury and death associated with renin angiotensin system blockade in cardiothoracic surgery: a meta-analysis of observational studies. Yacoub R; Patel N; Lohr JW; Rajagopalan S; Nader N; Arora P Am J Kidney Dis; 2013 Dec; 62(6):1077-86. PubMed ID: 23791246 [TBL] [Abstract][Full Text] [Related]
52. [Stroke and renin-angiotensin system]. Tanahashi N Nihon Rinsho; 2006 Jun; 64(6):1191-9. PubMed ID: 16768130 [TBL] [Abstract][Full Text] [Related]
53. Hepatocyte growth factor promotes an anti-inflammatory cytokine profile in human abdominal aortic aneurysm tissue. Shintani Y; Aoki H; Nishihara M; Ohno S; Furusho A; Hiromatsu S; Akashi H; Imaizumi T; Aoyagi S Atherosclerosis; 2011 Jun; 216(2):307-12. PubMed ID: 21411099 [TBL] [Abstract][Full Text] [Related]
54. Medical management of small abdominal aortic aneurysms. Baxter BT; Terrin MC; Dalman RL Circulation; 2008 Apr; 117(14):1883-9. PubMed ID: 18391122 [TBL] [Abstract][Full Text] [Related]
55. Current Theories and Clinical Trial Evidence for Limiting Human Abdominal Aortic Aneurysm Growth. Yu J; Liu S; Huang J; Wang W Curr Drug Targets; 2018; 19(11):1302-1308. PubMed ID: 29141546 [TBL] [Abstract][Full Text] [Related]
56. Update on the role of angiotensin in the pathophysiology of coronary atherothrombosis. da Silva AR; Fraga-Silva RA; Stergiopulos N; Montecucco F; Mach F Eur J Clin Invest; 2015 Mar; 45(3):274-87. PubMed ID: 25586671 [TBL] [Abstract][Full Text] [Related]
57. Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study. Hackam DG; Thiruchelvam D; Redelmeier DA Lancet; 2006 Aug; 368(9536):659-65. PubMed ID: 16920471 [TBL] [Abstract][Full Text] [Related]
58. Emerging Pharmacological Treatments to Prevent Abdominal Aortic Aneurysm Growth and Rupture. Fraga-Silva RA; Trachet B; Stergiopulos N Curr Pharm Des; 2015; 21(28):4000-6. PubMed ID: 26306842 [TBL] [Abstract][Full Text] [Related]
59. Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson's disease. Perez-Lloret S; Otero-Losada M; Toblli JE; Capani F Expert Opin Investig Drugs; 2017 Oct; 26(10):1163-1173. PubMed ID: 28836869 [TBL] [Abstract][Full Text] [Related]
60. Renin-angiotensin system inhibitors as therapeutic alternatives in the treatment of chronic liver diseases. Yoshiji H; Noguchi R; Ikenaka Y; Kitade M; Kaji K; Tsujimoto T; Uemura M; Fukui H Curr Med Chem; 2007; 14(26):2749-54. PubMed ID: 18045121 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]